BioProcess Theater, Day 1

10:00 AM - 4:15 PM, Tuesday, June 4, 2019 ・ BioProcess Theater: Booth #3211
Since 2008, the BPI Theater, a live, interactive amphitheater located at the heart of the BioProcess Zone (booth #3211), provides biopharmaceutical professionals with a dedicated destination to meet, network, listen and learn about the latest scientific, technology, business, and financial trends impacting biopharmaceutical research, development, and manufacturing. In 2019, this live, three-day, complimentary event consists of targeted panel discussions and individual presentations focusing on: Emerging Therapies: Cell & Gene Therapies, Viral Vectors/Vaccines, Manufacturing Strategies for Therapeutic Modalities, Capacity Challenges & Opportunities Emerging Techniques & Technologies: Drug Product Supply Challenges, Speed to Market, Capacity vs. Cost, SUS vs, Stainless, Analytics & Formulation, Single-Use Bioprocessing *Open to all attendees Tuesday, June 4 EMERGING THERAPIES BioProcess Insider Daily- One-on-One Live Executive Interviews 10:00 am - 11:00 am Kicking off the BPI Theater on both Tuesday and Wednesday mornings are face to face interviews conducted by Dan Stanton, veteran industry journalist and editor of BioProcess Insider 10:00 am - 10:15 am: Konstantin Matenzoglu, CEO, CELONIC Group 10:15 am - 10:30 am: Catarina Flyborg, GM, Cell and Gene Therapy Business, GE Healthcare 10:30 am - 10:45 am: Maurice Phelan, Site Head of Cambridge US, Sartorius Stedim Biotech 10:45 am - 11:00 am: Jennifer Cannon, VP of Operations Commercial Development, ABBVIE The Cocoon Platform, a Kaleidoscope Approach to Cell Therapy Manufacturing 11:00 am - 11:20 am Speaker: Matthew M. Hewitt Ph.D., Head of Clinical Development, Lonza Walkersville Standardized Plasmids for Viral Vector Production 11:20 am - 11:40 am Speaker: James Brown, Ph.D., Vice President of Corporate Development, Aldevron Moving Gene Therapies to Market: The Role of Manufacturing Technologies 11:40 am - 12:00 pm Speaker: Clive Glover, Director of Strategy, Gene and Cell Therapy, Pall Biotech PANEL DISCUSSION Cell/Gene/Immuno-Oncology Therapy Modalities - Why Develop One Modality Type vs. Another? How Does This Impact Manufacturing Strategies? 12:00 pm - 12:45 pm Chair: Patricia Seymour, Managing Director, BPTG, BDO USA Panelists: Al Gianchetti, President and CEO, XyloCor Alan Moore, VP & Commercial Chief for Advanced Therapies, WuXi Advanced Therapies Susan Jones, SVP Development, Harpoon Diane Blumenthal, Head of Technical Operations, Spark Therapeutics, Inc. Gene Therapy Product Analysis: Where Historical and Modern Techniques Meet 12:45 pm - 1:05 pm Speaker: Dr. Andy Topping, CSO, FUJIFILM Diosynth Technologies Single-Use Stir Tank Bioreactors: A Commercially Viable Strategy for Cell Therapy Manufacturing 1:05 pm - 1:25 pm Speaker: Alex Klarer, Biomedical Engineer, Hitachi Chemical Advanced Therapeutics Solutions *Sponsored by: Distek Emerging Therapy Development: Raising the Probability of Success 1:25 pm - 1:45 pm Speaker: Maurice Phelan, Site Head of Cambridge US, Cell Line & Testing Solutions, Sartorius Stedim Biotech PANEL DISCUSSION Cell and Gene Therapies: Keep it in-house or use a third-party? 1:45 pm - 2:30 pm Chair: Dan Stanton, BioProcess Insider Panelists: Bruce Levine, President Elect, ISCT Joseph Rininger, Ph.D., Director, Cell Gene Therapy, Latham Biopharm Group Felix Hsu, SVP and Global Head, WuXi Advanced Therapies Soenke Brunswieck, Head of Cell Gene Therapy, CELONIC Group Joe Vitale, Ph.D., Director, Account Management, Hitachi Chemical Process Development of a Closed CAR T Manufacturing Process 2:30 pm- 2:50 pm Speaker: Rohin Ilyer, Ph.D., Development Manager, Cell Therapy, GE Healthcare PANEL DISCUSSION Harnessing AI & Machine Learning to Improve R&D Efficiency and Reproducibility 2:50 pm - 3:30 pm Chair: Mike Ward, Chief Content Officer, Informa Pharma Intelligence Panelists: Magdalena Paluch, Co-Founder & CEO, LabTwin GmbH Ron Alfa, SVP, Translational Discovery Recurison Pharmaceuticals John Piccone, ZS Associates Krishnan Nandabalan, President & CEO, InveniAI Corporation Seth Lederman, CEO & Chariman, TONIX Pharmaceuticals PANEL DISCUSSION Start-Up Sourcebook: How to Jump 5 Unforeseen Hurdles to Biotech Success 3:30 pm - 4:15 pm Chair: Lisa LaMotta, Associate Director of Marketing and Communications, SmartLabs Panelists: Panelist: Ramani Varanasi, CEO, X-Biotix Therapeutics Panelist: Chris Haskell, Head of West Coast Innovation Center, Bayer Healthcare Panelist: Dan Geffken, Co-Founder, Danforth Advisors Panelist: Luba Greenwood, Business Development & Corporate Ventures, Google’s Verily Panelist: Ailis Tweed-Kent, CEO, Cocoon Biotech Panelist: Teresa Lavoie, Principal, Fish & Richardson